Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on l...Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.展开更多
目的调查肝硬化患者肝移植前后生存质量的变化情况。方法研究对象为在中山大学附属第三医院移植中心行首次肝移植手术的68例肝硬化患者。分别在术前,术后0～6个月、7～12个月、12个月以上对患者进行问卷调查。问卷采用健康调查简表(medi...目的调查肝硬化患者肝移植前后生存质量的变化情况。方法研究对象为在中山大学附属第三医院移植中心行首次肝移植手术的68例肝硬化患者。分别在术前,术后0～6个月、7～12个月、12个月以上对患者进行问卷调查。问卷采用健康调查简表(medical outcome study 36-item short form health survey,SF-36)与疾病专用调查表——慢性肝病问卷(chronic liver disease questionaire,CLDQ)。结果在肝移植术前,肝硬化患者的SF-36和CLDQ各维度评分均偏低。术后各时段SF-36的生理机能、躯体疼痛、一般健康、精力和CLDQ的腹部症状、乏力、全身症状、活动评分均较术前明显升高(均为P<0.05);与术前比较,术后0～6个月SF-36的生理职能、社会功能、情感职能、精神健康和CLDQ的情感功能、焦虑评分差异无统计学意义(均为P>0.05),但术后7～12个月、术后12个月以上述维度评分比较差异均有统计学意义(均为P<0.05);术后随着时间的推移,两表各维度得分逐步升高。结论肝硬化肝移植患者术后的生存质量与术前比较有明显改善,术后早期以生理功能方面改善明显,随时间的推移,生存质量其他指标如心理状态和社会功能也得到明显的改善。展开更多
目的观察疏肝健脾合养心安神方治疗功能性消化不良(functional dyspepsia,FD)伴有焦虑抑郁状态的疗效。方法将90例FD伴焦虑抑郁状态的患者随机分为疏肝组、疏肝养心组和疏肝黛力新组,分别治以中药疏肝健脾方、中药疏肝健脾方+养心安神方...目的观察疏肝健脾合养心安神方治疗功能性消化不良(functional dyspepsia,FD)伴有焦虑抑郁状态的疗效。方法将90例FD伴焦虑抑郁状态的患者随机分为疏肝组、疏肝养心组和疏肝黛力新组,分别治以中药疏肝健脾方、中药疏肝健脾方+养心安神方,及中药疏肝健脾方+黛力新,治疗前后观察3组患者脾胃症状评分,采用36条目生活质量简表(36-item short form health survey questionnaire,SF-36)评价患者治疗前后的生活质量,采用汉密尔顿焦虑量表(Hamilton anxiety scale,HAMA)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD)评价患者治疗前后的焦虑抑郁水平。结果疏肝养心组、疏肝黛力新组在改善FD患者脾胃症状,降低HAMA、HAMD评分,改善SF-36各维度评分方面显著优于疏肝组(P<0.05,或P<0.01);疏肝养心组与疏肝黛力新组疗效比较,差异无统计学意义(P>0.05)。结论疏肝健脾方合养心安神方可明显改善FD伴焦虑抑郁状态患者的脾胃症状,并可改善焦虑抑郁症状,提高生活质量。展开更多
目的调查分析慢性再生障碍性贫血患者的社会回归情况及生活质量情况。为临床护理人员针对慢性再生障碍性贫血患者护理领域的延伸提供参考依据。方法选择2016-01-04—2017-12-31于某院治疗符合社会回归标准的慢性再生障碍性贫血患者119例...目的调查分析慢性再生障碍性贫血患者的社会回归情况及生活质量情况。为临床护理人员针对慢性再生障碍性贫血患者护理领域的延伸提供参考依据。方法选择2016-01-04—2017-12-31于某院治疗符合社会回归标准的慢性再生障碍性贫血患者119例,以问卷方式调查患者社会回归现状,并调取患者近期血常规情况,用健康状况问卷量表(short form 36 health survey questionnaire,SF-36)评估慢性再生障碍性贫血患者的生活质量。根据调查结果比较社会回归级别不同的慢性再生障碍性贫血患者之间生活质量的差别。结果随着社会回归级别的增加,患者总体生活质量逐级增加,各级间差异有高度统计学意义(P<0.01),特别是所占比例最大的3级患者生活质量明显受情绪、社会因素的影响。结论慢性再生障碍性贫血患者社会回归情况欠佳,生活质量受病情、心理制约。展开更多
目的:探讨甲状旁腺全切术(total parathyroidectomy,TPTX)对维持性血液透析(maintenance hemodialysis,MHD)患者临床指标及生活质量的影响。方法:回顾性分析89例继发性甲状旁腺功能亢进症(secondary hyperparathyroidism,SHPT)患者手术...目的:探讨甲状旁腺全切术(total parathyroidectomy,TPTX)对维持性血液透析(maintenance hemodialysis,MHD)患者临床指标及生活质量的影响。方法:回顾性分析89例继发性甲状旁腺功能亢进症(secondary hyperparathyroidism,SHPT)患者手术前后血清钙、磷、全段甲状旁腺激素(intact parathyroid hormone,IPTH)、碱性磷酸酶、血红蛋白、白蛋白等生化指标变化,应用肾脏病与生活质量问卷36(kidney disease quality of life 36,KDQOL-36)量表和36项简明健康调查问卷(the medical outcome 36-item short form health survey,SF-36)量表对患者进行手术前、后生活质量评估,比较手术前、后生活质量评分变化。结果:术后患者乏力、骨痛、皮肤瘙痒等症状明显改善。术后血清钙、磷、碱性磷酸酶、IPTH较术前明显下降(均P<0.01),血红蛋白、白蛋白较术前明显增加(P<0.01)。术前生活质量评分均较低,TPTX后生活质量评分均显著增加(P<0.01)。术前肾病相关生活质量、一般健康相关生活质量、综合生活质量与血红蛋白、白蛋白呈正相关,与年龄呈负相关(均P<0.05);肾病相关生活质量、综合生活质量与文化程度呈正相关(均P<0.05);一般健康相关生活质量与血清尿素氮、磷呈负相关(均P<0.05)。结论:TPTX可以显著改善难治性SHPT患者的临床指标,提高生活质量。展开更多
文摘Objectives: Osteoarthritis (OA) has a dramatic impact on patients’ health related quality of life (HRQoL). Chronic use of analgesics and anti-inflammatory medications for pain management may improve symptoms but on long term may affect HRQoL negatively. The objective of the present study was to compare the impact of two different classes of analgesics, traditional non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclo-oxygenase-2 (COX-2) inhibitors on HRQoL among osteoarthritis patients using the SF-36 questionnaire. Methods: Clinic based cross-sectional study conducted at Al-Qassimi Hospital, Sharjah, United Arab Emirates (UAE), over a period of six months. Ethical Approval was obtained from the ethics committee at Al-Qassimi Clinical Research Center. Total of 200 osteoarthritis patients fulfilling the inclusion and exclusion criteria were involved in the study. Patients’ demographics were collected from their medical records. The Medical Outcome Study Short-Form 36 (SF-36) questionnaire was used to measure patients’ HRQoL. SF-36 data were scored using health outcomes scoring software 4.5. Results: Mean age of the subjects was 62.19 ± 9.81 years with females constituting 151 (75.5%) of the patients. In general, females scored lower in most of the HRQoL domains compared to males and there was significant difference between the two groups in the mental health (p = 0.005) & mental component (p = 0.042) domains. Compared to selective COX-2 inhibitors, patients on NSAIDs scored higher on all domains of SF-36 except physical functioning. There was significant difference in mental health domain for patients treated with NSAIDs (p = 0.02). Celecoxib was only better than NSAIDs in osteoarthritis patients with more than one musculoskeletal disorders in the domain of bodily pain (p = 0.009). Conclusion: NSAIDs-treated patients did not differ significantly from celecoxib-treated patients in all domains of the SF-36 except for the mental health domain.
文摘目的调查肝硬化患者肝移植前后生存质量的变化情况。方法研究对象为在中山大学附属第三医院移植中心行首次肝移植手术的68例肝硬化患者。分别在术前,术后0～6个月、7～12个月、12个月以上对患者进行问卷调查。问卷采用健康调查简表(medical outcome study 36-item short form health survey,SF-36)与疾病专用调查表——慢性肝病问卷(chronic liver disease questionaire,CLDQ)。结果在肝移植术前,肝硬化患者的SF-36和CLDQ各维度评分均偏低。术后各时段SF-36的生理机能、躯体疼痛、一般健康、精力和CLDQ的腹部症状、乏力、全身症状、活动评分均较术前明显升高(均为P<0.05);与术前比较,术后0～6个月SF-36的生理职能、社会功能、情感职能、精神健康和CLDQ的情感功能、焦虑评分差异无统计学意义(均为P>0.05),但术后7～12个月、术后12个月以上述维度评分比较差异均有统计学意义(均为P<0.05);术后随着时间的推移,两表各维度得分逐步升高。结论肝硬化肝移植患者术后的生存质量与术前比较有明显改善,术后早期以生理功能方面改善明显,随时间的推移,生存质量其他指标如心理状态和社会功能也得到明显的改善。
文摘目的观察疏肝健脾合养心安神方治疗功能性消化不良(functional dyspepsia,FD)伴有焦虑抑郁状态的疗效。方法将90例FD伴焦虑抑郁状态的患者随机分为疏肝组、疏肝养心组和疏肝黛力新组,分别治以中药疏肝健脾方、中药疏肝健脾方+养心安神方,及中药疏肝健脾方+黛力新,治疗前后观察3组患者脾胃症状评分,采用36条目生活质量简表(36-item short form health survey questionnaire,SF-36)评价患者治疗前后的生活质量,采用汉密尔顿焦虑量表(Hamilton anxiety scale,HAMA)、汉密尔顿抑郁量表(Hamilton depression scale,HAMD)评价患者治疗前后的焦虑抑郁水平。结果疏肝养心组、疏肝黛力新组在改善FD患者脾胃症状,降低HAMA、HAMD评分,改善SF-36各维度评分方面显著优于疏肝组(P<0.05,或P<0.01);疏肝养心组与疏肝黛力新组疗效比较,差异无统计学意义(P>0.05)。结论疏肝健脾方合养心安神方可明显改善FD伴焦虑抑郁状态患者的脾胃症状,并可改善焦虑抑郁症状,提高生活质量。
文摘目的调查分析慢性再生障碍性贫血患者的社会回归情况及生活质量情况。为临床护理人员针对慢性再生障碍性贫血患者护理领域的延伸提供参考依据。方法选择2016-01-04—2017-12-31于某院治疗符合社会回归标准的慢性再生障碍性贫血患者119例,以问卷方式调查患者社会回归现状,并调取患者近期血常规情况,用健康状况问卷量表(short form 36 health survey questionnaire,SF-36)评估慢性再生障碍性贫血患者的生活质量。根据调查结果比较社会回归级别不同的慢性再生障碍性贫血患者之间生活质量的差别。结果随着社会回归级别的增加,患者总体生活质量逐级增加,各级间差异有高度统计学意义(P<0.01),特别是所占比例最大的3级患者生活质量明显受情绪、社会因素的影响。结论慢性再生障碍性贫血患者社会回归情况欠佳,生活质量受病情、心理制约。
文摘目的:探讨甲状旁腺全切术(total parathyroidectomy,TPTX)对维持性血液透析(maintenance hemodialysis,MHD)患者临床指标及生活质量的影响。方法:回顾性分析89例继发性甲状旁腺功能亢进症(secondary hyperparathyroidism,SHPT)患者手术前后血清钙、磷、全段甲状旁腺激素(intact parathyroid hormone,IPTH)、碱性磷酸酶、血红蛋白、白蛋白等生化指标变化,应用肾脏病与生活质量问卷36(kidney disease quality of life 36,KDQOL-36)量表和36项简明健康调查问卷(the medical outcome 36-item short form health survey,SF-36)量表对患者进行手术前、后生活质量评估,比较手术前、后生活质量评分变化。结果:术后患者乏力、骨痛、皮肤瘙痒等症状明显改善。术后血清钙、磷、碱性磷酸酶、IPTH较术前明显下降(均P<0.01),血红蛋白、白蛋白较术前明显增加(P<0.01)。术前生活质量评分均较低,TPTX后生活质量评分均显著增加(P<0.01)。术前肾病相关生活质量、一般健康相关生活质量、综合生活质量与血红蛋白、白蛋白呈正相关,与年龄呈负相关(均P<0.05);肾病相关生活质量、综合生活质量与文化程度呈正相关(均P<0.05);一般健康相关生活质量与血清尿素氮、磷呈负相关(均P<0.05)。结论:TPTX可以显著改善难治性SHPT患者的临床指标,提高生活质量。
